Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys Plus Entecavir vs Monotherapies in HBeAg-Negative CHB
NCT01925820Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Jan 2013
- Primary completion
- Dec 2018
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of interferon alfa in Chronic Hepatitis B (CHB), sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
interferon alfa
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01925820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01925820.